|
| Exchange Disseminated Time 02/02/2016 11:41:56 | Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 12, 2016, inter alia, to consider and take on record the following matters:
1. Unaudited (Provisional) Financial Result for the quarter ended December 31, 2015 along with the Limited Review Report as submitted by the Statutory Auditors of the Company.
2. Adoption of SEBI (Listing Obligations and Disclosure Requirements] Regulations, 2015 including authorizing any Director of the Company to enter into amended Listing Agreement and submission of the same to BSE & NSE and any other applicable authorities, if required.
- Closure of Trading window :
The Company will close the trading window in compliance with SEBI (Prohibition of Insider Trading] Regulations on February 01, 2016 and the trading window will open on February 15, 2016. |
|
|